Agenda Topics- 3D-Cell Culture Based Models
- High-Content Screening and Imaging Technologies
- iPSC-derived Cells for Toxicity Testing and Pharmaceutical Screening
- Organoids
- Phenotypic and High Content Screening of 3D-Model Systems
- Phenotypic Drug Discovery
- Screening Technologies, Instrumentation and Reagents
- Stem Cells in Drug Discovery and Toxicity Screening
- Technologies in 3D-Cell Culture
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateMurat Cirit, Director at Translational Center of Tissue Chip Technologies, Massachusetts Institute of Technology (MIT) Maciej Daniszewski, Researcher, University of Melbourne Christina Fey, Researcher, Tissue Engineering and Regenerative Medicine, University hospital Würzburg Nikolas Gaio, CTO, BI/OND Solutions B.V. Robert Halliwell, Professor of Neuroscience, University of The Pacific Bram Herpers, COO, OcellO B V Jens Kelm, CEO and Co-Founder, PreComb Therapeutics AG Feng Li, Senior Scientist, Development, Corning Life Sciences Jan Lichtenberg, CEO and Co-Founder, InSphero AG Jan Markus, Production Manager/Senior Scientist, MatTek IVLSL Grégory Maubon, Digital Coordinator, HCS Pharma Nathalie Maubon, CEO/CSO, HCS Pharma David Pamies, Researcher, University of Lausanne Sara Previdi, Scientist, University Medical Center Leiden Silvia Scaglione, Professor, National Council of Research (CNR), Genoa (Italy) and Head of Laboratory of Tissue Engineering Katharina Schimek, Senior Scientist and Project Manager, TissUse GmbH Glauco Souza, Director of Global Business Development and Innovation, 3D Cell Culture at Greiner Bio-One; Adjunct Assistant Professor, Greiner Bio-One and University of Texas Health Science Center at Houston Corné Swart, Head of Business Development, Cellbox Solutions GmbH Daniele Zink, Principal Research Scientist and Team Leader, Institute of Bioengineering and Nanotechology, Agency for Science Technology and Research (A*STAR)
|